Showing results (181-190 of 237) with videos related to
Sort By:
Pageof 24
Nanomedicine : Nanotechnology, Biology, and Medicine|October 11, 2016
An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapyDerrick P McCarthy, Jonathan Woon-Teck Yap, Christopher T Harp, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 9, 2017
Controlled Delivery of Single or Multiple Antigens in Tolerogenic Nanoparticles Using Peptide-Polymer BioconjugatesRyan M Pearson, Liam M Casey, Kevin R Hughes, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 15, 2012
Ethylenecarbodiimide-fixed donor splenocyte infusions differentially target direct and indirect pathways of allorecognition for induction of transplant toleranceTaba Kheradmand, Shusen Wang, Jane Bryant, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 25, 2010
NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responsesDenis Gris, Zhengmao Ye, Heather A Iocca, et al.Neurobiology of Disease|August 22, 2017
Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in miceSu Ji Jeong, John G Cooper, Igal Ifergan, et al.The Journal of Clinical Investigation|November 3, 2004
A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetesUrs Christen, Kurt H Edelmann, Dorian B McGavern, et al.Journal of Neuroinflammation|May 31, 2024
Therapeutic role of interferon-γ in experimental autoimmune encephalomyelitis is mediated through a tolerogenic subset of splenic CD11b+ myeloid cellsGabriel Arellano, Eric Acuña, Eileah Loda, et al.Proceedings of the National Academy of Sciences of the United States of America|September 18, 2008
ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanismsXunrong Luo, Kathryn L Pothoven, Derrick McCarthy, et al.Biotechnology and Bioengineering|October 12, 2022
Nanoparticle dose and antigen loading attenuate antigen-specific T-cell responsesLiam M Casey, Joseph T Decker, Joseph R Podojil, et al.Arthritis Research & Therapy|July 14, 2011
Characterization of a novel and spontaneous mouse model of inflammatory arthritisIris A Adipue, Joel T Wilcox, Cody King, et al.Pageof 24